Broussonetine ACAS# 173220-07-0 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 173220-07-0 | SDF | Download SDF |
PubChem ID | 177262 | Appearance | Powder |
Formula | C24H45NO10 | M.Wt | 507.62 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 1-hydroxy-13-[(3R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypyrrolidin-2-yl]tridecan-4-one | ||
SMILES | C(CCCCC1C(C(C(N1)CO)O)OC2C(C(C(C(O2)CO)O)O)O)CCCCC(=O)CCCO | ||
Standard InChIKey | LYIJINGICVFWEP-OWASOCSESA-N | ||
Standard InChI | InChI=1S/C24H45NO10/c26-12-8-10-15(29)9-6-4-2-1-3-5-7-11-16-23(19(30)17(13-27)25-16)35-24-22(33)21(32)20(31)18(14-28)34-24/h16-28,30-33H,1-14H2/t16?,17-,18-,19+,20-,21+,22-,23-,24+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Broussonetines A-H are glycosidase inhibitors. |
Broussonetine A Dilution Calculator
Broussonetine A Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.97 mL | 9.8499 mL | 19.6998 mL | 39.3996 mL | 49.2494 mL |
5 mM | 0.394 mL | 1.97 mL | 3.94 mL | 7.8799 mL | 9.8499 mL |
10 mM | 0.197 mL | 0.985 mL | 1.97 mL | 3.94 mL | 4.9249 mL |
50 mM | 0.0394 mL | 0.197 mL | 0.394 mL | 0.788 mL | 0.985 mL |
100 mM | 0.0197 mL | 0.0985 mL | 0.197 mL | 0.394 mL | 0.4925 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Clomipramine HCl
Catalog No.:BCC5036
CAS No.:17321-77-6
- 4-Beta-Hydroxycholesterol
Catalog No.:BCN2752
CAS No.:17320-10-4
- SQ 22536
Catalog No.:BCC7065
CAS No.:17318-31-9
- Centaureidin
Catalog No.:BCN2575
CAS No.:17313-52-9
- Ganoderic acid DM
Catalog No.:BCN1113
CAS No.:173075-45-1
- Rhoifolin
Catalog No.:BCN1112
CAS No.:17306-46-6
- Rec 15/2615 dihydrochloride
Catalog No.:BCC7628
CAS No.:173059-17-1
- PMPA (NAALADase inhibitor)
Catalog No.:BCC2354
CAS No.:173039-10-6
- Goniothalamin
Catalog No.:BCN4690
CAS No.:17303-67-2
- Poloxime
Catalog No.:BCC5307
CAS No.:17302-61-3
- Isoanthricin
Catalog No.:BCN3531
CAS No.:17301-70-5
- BWX 46
Catalog No.:BCC5865
CAS No.:172997-92-1
- 2,5-Dihydroxy-1-methoxyxanthone
Catalog No.:BCN7577
CAS No.:173220-32-1
- TC-E 5003
Catalog No.:BCC8008
CAS No.:17328-16-4
- Garciniaxanthone E
Catalog No.:BCN1114
CAS No.:173294-74-1
- Isorhamnetin 3-glucoside-7-rhamnoside
Catalog No.:BCN1528
CAS No.:17331-71-4
- Aliskiren
Catalog No.:BCC1338
CAS No.:173334-57-1
- Aliskiren Hemifumarate
Catalog No.:BCC5018
CAS No.:173334-58-2
- Pelargonidin-3,5-O-diglucoside chloride
Catalog No.:BCN1527
CAS No.:17334-58-6
- Afobazole
Catalog No.:BCC5386
CAS No.:173352-21-1
- Rotundanonic acid
Catalog No.:BCN7152
CAS No.:173357-19-2
- Ficusin A
Catalog No.:BCN1115
CAS No.:173429-83-9
- HMN-214
Catalog No.:BCC2517
CAS No.:173529-46-9
- Naphthoquine phosphate
Catalog No.:BCC1784
CAS No.:173531-58-3
Studies on the constituents of Broussonetia species. II. Six new pyrrolidine alkaloids, broussonetine A, B, E, F and broussonetinine A and B, as inhibitors of glycosidases from Broussonetia kazinoki Sieb.[Pubmed:9145506]
Chem Pharm Bull (Tokyo). 1997 Apr;45(4):700-5.
Six new pyrrolidine alkaloids called Broussonetine A, B, E, F, and broussonetinine A and B were isolated from the branches of Broussonetia kazinoki Sieb. (Moraceae). Broussonetine A, B, E and F were formulated as 2 beta-hydroxymethyl-3 beta-hydroxy-5-alpha- (10-oxo-13-hydroxytridecyl)-pyrrolidine-4-O-beta-D-glucopyranoside (1), 2 beta-hydroxymethyl-3 beta-hydroxy-5 alpha-(9-oxo-13-hydroxytridecyl)-pyrrolidine-4-O-beta-D-glucopy ran oside (2), 2 beta-hydroxymethyl-3 alpha,4 beta-dihydroxy-5 alpha-(1,13-dihydroxy-10-oxo-tridecyl)-pyrrolidine (3), and 2 beta-hydroxymethyl-3 alpha,4 beta-dihydroxy-5 alpha-(1,13-dihydroxy-9-oxo-tridecyl)-pyrrolidine (4), respectively. Broussonetinine A and B (5 and 6) were also isolated and identified as the aglycones of 1 and 2. 3 and 4 exhibited a strong inhibition of alpha-glucosidase, beta-glucosidase, beta-galactosidase and beta-mannosidase, while 5 and 6 showed a strong inhibition of beta-galactosidase and alpha-mannosidase.